In recent years, more and more evidence suggests that PDK1 is associated with tumor progression and metastasis (27–29), which provides a new idea for the development of targeting PDK1 for the treatment of osteosarcoma, as evidenced by Liu et al. The gene discussed is PDK1; the disease is osteosarcoma.